Christopher E. Hodge (Chris)

Associate

San Diego + 1.858.314.1187

Connect:

Share

Chris Hodge is a patent litigator with additional experience in international trade secret litigation, technology licensing, patent prosecution, and corporate litigation. Chris utilizes his electrical engineering background to assist clients on high-tech patent and trade secret matters ranging from drafting infringement/invalidity contentions, dispositive motions, written discovery, discovery disputes and document collection, trial preparation and strategy, and claim construction briefing. He also has experience in technology licensing support, litigation research, and working with fact and expert witnesses to develop testimony and expert opinions.

Chris's intellectual property practice involves numerous technologies in the high-tech and biotech areas, including: 5G cellular communications, artificial intelligence (AI), pharmacy benefits management, bioinformatics, semiconductor devices, optical network architecture, field-programable gate array (FPGA), memory systems, radio-frequency identification tags (RFID), and software architecture. Chris previously worked as a research assistant to simulate and model advancements in control systems, where he developed a technical background in VHDL (very high-speed integrated circuit hardware description language), MATLAB (matrix laboratory), LTSpice (circuit simulator), and Python (programming language).

Chris also actively supports the Firm's pro bono initiatives, including assisting clients with navigating asylum proceedings with Jones Day's Border Project and discovery support for Jones Day's Constitutional Policing and Civil Justice Reform (CPR) Initiative.

Experience

  • Chemtronics resolves patent infringement claims involving touch screen technologyJones Day represented Chemtronics Co., Ltd. against a competitor in a patent infringement case in the Eastern District of Texas.
  • NXP litigates against competitor in 18-patent suit directed to RFID technologyJones Day represented NXP USA Inc. and NXP Semiconductors Netherlands B.V. in a patent infringement lawsuit against its competitor Impinj, Inc. in the Western District of Texas.
  • NXP sues Impinj for infringing patents relating to RFID technologyJones Day represented NXP USA, Inc. and NXP B.V. in their enforcement of six radio frequency identification (RFID) and wafer-layout patents against Impinj, Inc.
  • NXP whittles down competitor's infringement suit involving RFID technology from 26 to four patentsJones Day defended NXP USA, Inc. in a lawsuit brought by its competitor Impinj, Inc. alleging infringement of 26 patents relating to different aspects of radio frequency identification (RFID) technology.
  • Micron Technology asserts trade secret and RICO claims, establishes U.S. jurisdiction over foreign defendants under DTSAJones Day represented Micron Technology, Inc. as a plaintiff in a trade secret and RICO lawsuit against Taiwanese and Chinese entities accused of theft of Micron's semiconductor processing technology.
  • Xilinx defeats all infringement claims brought by WSOU Investments asserting Alcatel-Lucent patent portfolioJones Day successfully defended Xilinx, Inc. against five patent infringement cases filed by plaintiff WSOU d/b/a Brazos asserting Alcatel-Lucent patents related to optical networks, power management, and clock generation.
  • Charles Schwab Bank resolves infringement claims involving fintech patentsJones Day defended Charles Schwab Bank in a patent infringement case before Judge Alan Albright in the Western District of Texas involving fintech technology.
    • View All

    June 2021 Blog

    Telepharma Disconnect: Federal Circuit Reverses PTAB on Obviousness, PTAB Litigation Blog

    December 2020 Blog

    PRECEDENTIAL: PTAB Declines To Resolve RPI Dispute, PTAB Litigation Blog

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.